Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P62736: Variant p.Arg149Cys

Actin, aortic smooth muscle
Gene: ACTA2
Feedback?
Variant information Variant position: help 149 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Cysteine (C) at position 149 (R149C, p.Arg149Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AAT6. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 149 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 377 The length of the canonical sequence.
Location on the sequence: help FNVPAMYVAIQAVLSLYASG R TTGIVLDSGDGVTHNVPIYE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         FNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYE

Mouse                         FNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYE

Rat                           FNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYE

Bovine                        FNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYE

Rabbit                        FNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYE

Chicken                       FNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYE
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 377 Actin, aortic smooth muscle, intermediate form
Chain 3 – 377 Actin, aortic smooth muscle



Literature citations
Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.
Guo D.-C.; Pannu H.; Tran-Fadulu V.; Papke C.L.; Yu R.K.; Avidan N.; Bourgeois S.; Estrera A.L.; Safi H.J.; Sparks E.; Amor D.; Ades L.; McConnell V.; Willoughby C.E.; Abuelo D.; Willing M.; Lewis R.A.; Kim D.H.; Scherer S.; Tung P.P.; Ahn C.; Buja L.M.; Raman C.S.; Shete S.S.; Milewicz D.M.;
Nat. Genet. 39:1488-1493(2007)
Cited for: VARIANTS AAT6 THR-117; GLN-118; HIS-135; CYS-149; ALA-154; CYS-258; HIS-258; GLY-292 AND ASN-353; Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease.
Guo D.-C.; Papke C.L.; Tran-Fadulu V.; Regalado E.S.; Avidan N.; Johnson R.J.; Kim D.H.; Pannu H.; Willing M.C.; Sparks E.; Pyeritz R.E.; Singh M.N.; Dalman R.L.; Grotta J.C.; Marian A.J.; Boerwinkle E.A.; Frazier L.Q.; LeMaire S.A.; Coselli J.S.; Estrera A.L.; Safi H.J.; Veeraraghavan S.; Muzny D.M.; Wheeler D.A.; Willerson J.T.; Yu R.K.; Shete S.S.; Scherer S.E.; Raman C.S.; Buja L.M.; Milewicz D.M.;
Am. J. Hum. Genet. 84:617-627(2009)
Cited for: VARIANTS AAT6 HIS-39; THR-117; GLN-118; CYS-149; ALA-154; GLN-185; GLN-212; HIS-258; CYS-258; ASN-326 AND ASN-353; Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD).
Morisaki H.; Akutsu K.; Ogino H.; Kondo N.; Yamanaka I.; Tsutsumi Y.; Yoshimuta T.; Okajima T.; Matsuda H.; Minatoya K.; Sasaki H.; Tanaka H.; Ishibashi-Ueda H.; Morisaki T.;
Hum. Mutat. 30:1406-1411(2009)
Cited for: VARIANTS AAT6 CYS-145; CYS-149 AND GLN-212; PREDISPOSITION TO A VARIETY OF VASCULAR DISEASES;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.